KKR has announced it has closed its newest fund, KKR North America Fund XIII, with $19 billion.
The fund, which will focus on pursuing private equity investments in North America, was oversubscribed.
The private equity platform of Kohlberg Kravis Roberts (KKR)
On April 25, 2022, the Consumer Financial Protection Bureau (CFPB) announced that it will begin examining nonbank “covered persons” that it has determined pose risks to consumers. The CFPB has had this authority since its inception. The Dodd-Frank Act empowered
TPG Capital has agreed to acquire ClaimsXten, Change Healthcare’s claims editing business, from UnitedHealth for $2.2 billion, according to news reports.
The sale of ClaimsXten will only proceed if UnitedHealth’s acquisition of Change Healthcare is completed. The acquisition is
This Week in Washington: White House Releases National Drug Control Strategy
Congress
House
Reps. Rodgers, Guthrie and Griffith Call on Secretary Becerra to Investigate Cause of Overdose Deaths
On April 20, Reps. Cathy McMorris Rodgers (R-WA), Brett Guthrie (R-KY)
On April 20, 2022, the U.S. Department of Justice (DOJ) and Securities and Exchange Commission (SEC) separately announced that Stericycle Inc. (Stericycle), an international waste management company headquartered in Lake Forest, Illinois, has agreed to pay more than $84 million
Clayton, Dubilier & Rice (CD&R) will acquire the hospice and personal care divisions of Humana’s Kindred at Home (KAH) subsidiary for about $2.8 billion, according to a news release.
The transacted divisions include patient-centered services for hospice, palliative, community and
Securities Exchange Commission v. David J. Bunevacz et al. was filed in the United States District Court for the Central District of California on April 5, 2022, seeking an injunctive relief, disgorgement, and civil penalties. Specifically, the complaint alleges violations
This Week in Washington: COVID-19 Public Health Emergency Extended for 90 More Days
Congress
The House and Senate are in a district work period this week.
Senate
Bipartisan Group Calls on Naloxone Manufacturers to Apply for Over-the-Counter Status
On April